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Lanthanides DOI: 10.1002/anie.201((will be filled in by the editorial staff)) 
Bright, highly water soluble triazacyclononane europium complexes 
 to detect ligand binding with time resolved-FRET microscopy** 
 Martina Delbianco, Victoria Sadovnikova+, Emmanuel Bourrier, Gérard Mathis, Laurent Lamarque, 
Jurriaan M. Zwier* and  David Parker* 
Abstract: Luminescent europium complexes are used in a broad 
range of applications due to their particular emissive properties. 
Here we describe the synthesis and application of bright, highly 
water soluble and negatively charged sulphonic- or carboxylic acid 
derivatives of p-substituted aryl-alkynyl triazcyclononane complexes. 
Introduction of the charged solubilizing moieties suppresses cellular 
uptake or adsorption to living cells making them applicable for 
labeling and performing assays on membrane receptors. These 
europium complexes are applied to monitor fluorescent ligand 
binding on cell surface proteins with time-resolved Förster 
Resonance Transfer assays in plate based format and using TR-
FRET microscopy.  
Luminescent lanthanide complexes are used in an impressive 
number of applications, such as sensors,[1, 2] bioassays[3], or 
OLEDs[4], due to their peculiar photophysical properties. Their use 
in luminescence based cellular imaging purposes has been 
particularly interesting, since background fluorescence from cells 
can be completely rejected using time-gating [1, 2, 5, 6]. A key 
challenge remains to develop bright probes to address specific 
biological processes in living cells or for cell tissue samples.[3, 7, 8] 
Recently, we have developed very bright europium 
triazacyclononane (TACN) complexes that stain various 
intracellular compartments, such as mitochondria, following cell 
uptake by macropinocytosis.[9-12] Such behavior is disadvantageous, 
if you seek to develop assays for membrane proteins, such as G-
protein coupled receptors [13, 14]. With all the previously developed 
complexes, [9-12] the non-specific interactions[3, 15]   due to the probe 
adsorbing to the cell membrane or proteins within,  cellular uptake 
or the labeling of immature proteins within the cytosol reached 
values not compatible with homogeneous time resolved 
fluorescence (HTRF) bioassays.[3] Here we describe the synthesis of 
europium TACN complexes and their bio-conjugates with improved 
water solubility that are incapable of entering or adhering to cells at 
concentrations <1 M. The bioconjugates were evaluated in TR-
FRET ligand binding assays on living cells expressing the 
cholecystokinin2 (CCK2) receptor both in plate based format as 
well using TR-FRET microscopy. 
Since the cell membrane consists of phospholipids and is considered 
to be negatively charged, we developed TACN complexes, which 
are highly water soluble and negatively charged at physiological pH 
(Scheme 1). We reasoned that this should reduce interaction with 
the cell membrane due to repulsive Coulombic interactions. 
Moreover, the hydrophilic nature of the sulphonate and carboxylate 
groups should masks the inherent hydrophobic nature of the three 
aryl-alkynyl groups. The emission spectrum and photo-physical 
properties of the parent complexes e.g. [EuL1] and the ring-
substituted analogues such as [EuL2] [16] do not change significantly, 
indicating that the local C3 symmetry around the Eu
3+-ion is not 
compromised. Hence, bio-conjugation of the complexes was 
initiated by using derivatives substituted at the ring carbon of the 
TACN macrocycle, e.g. those based on [Eu.L3]. This approach 
avoids varying the ring N-substituents, as asymmetry in the aryl-
alkynyl antennae complicates the synthesis.[9]  
 
 
 
 
 
 
  
Scheme 1.  Structures of parent and C-substituted Eu complexes 
The synthesis of these complexes was undertaken in a modular 
manner, using three key intermediates (Scheme 2). The C-
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substituted TACN intermediate, 1, was prepared using an adaptation 
of the literature method (see SI), [16] wherein copper binding to the 
three ring N atoms allows the remote primary amine to react 
selectively with Boc2O. Copper is rapidly removed by bubbling H2S 
through the solution, and the three ring N atoms were alkylated with 
the known pyridyl mesylate, 2 (Scheme 2) [9,11]. The benzylguanine 
moiety was introduced following reaction of the NHS ester, 3, with 
the primary amine on the ring substituent that had been unmasked 
by de-protection of the BOC precursor (TFA, RT).  
 
 
 
Scheme 2.  Retrosynthesis of the target Eu conjugates 
The water solubility of these and related complexes was 
compared by assessing the partitioning coefficient (logP) of the 
complexes in water/octanol mixtures. Three equimolar solutions of 
complex were prepared in MeOH. The solvent was removed under 
reduced pressure and the resulting solid was dissolved and stirred 
for 24 h in 0.9 mL of a mixture of water/octanol (2:1, 1:1, 1:2) 
giving a total concentration of approximately 2 M. After 
equilibration, an emission spectrum for each layer was recorded in 
MeOH (50 L of solution in 1 mL of MeOH). For each mixture, the 
logP value was calculated) (see SI). 
 
Table 1:  Photophysical properties and logP values of the [EuL
4
] complexes 
  (295K, H2O) 
 max / nm 0 / ms  / %   / mM
-1cm-1 logP 
[Eu.L
4a
] 330 1.03 24 58 +1.4 
[Eu.L
4b
] 330 1.04 28 58 -2.2 
[Eu.L
4c
] 330 1.01 26 58 -2.2 
 
The introduction of sulphonate or carboxylate groups enhances 
water solubility significantly, and reduces the logP value from +1.4 
to -2.2. The absorption and emission spectrum (Figure 1) and the 
excited state lifetimes hardly change when compared to the parent 
compounds[11], although the overall luminescence quantum yield in 
water drops slightly suggesting that the energy transfer from the 
ligand ICT excited state to Eu3+ is not quite as efficient in water as 
in methanol.[9]  
After solving the problem of water solubility, we evaluated the 
complexes using SNAP-tag technology.[17-21] on the cholecystokinin-
2 (CCK2) receptor, a G-protein coupled receptor, which has 
elevated expression levels when transiently transfected in HEK293 
cells. The labeling of the benzylguanine-derivatives [Eu.L5] [Eu.L6], 
and [Eu.L7] on living HEK293 cells or HEK293 cells expressing the 
SNAP-tagged CCK2 (SNAP-CCK2)[21] was measured by 
monitoring the time gated luminescence intensity at 620 nm (Figure 
2b-d).  
Significant labeling of non-transfected HEK293 cells occurs with 
the less hydrophilic compound [Eu.L5], whereas with [Eu.L6] and 
[Eu.L7] this non-specific labeling is negligible. These excellent 
results tempted us to perform a TR-FRET ligand binding assay 
using a fluorescent agonist of the CCK2 receptor. 
 
Figure 1  Absorption and total emission spectra for [Eu.L
4c
] (295K, water) 
Addition of increasing concentrations of the red fluorescent-agonist 
of CCK2, red-CCK(26-33)[21] to [Eu.L7] labeled living SNAP-
CCK2 cells and measuring the time resolved FRET at 665 nm 
results in a saturating binding curve (Figure 2e). Note that adding 10 
M of the natural agonist CCK-(26-33) at the different 
concentrations of fluorescent ligand the TR-FRET signal is 
annihilated due to the competition of non-labeled compound. By 
applying a one-site binding model to the specific binding data, a 
dissociation constant (Kd) of the red agonist of  8 nM was calculated, 
similar to data reported in the literature.[21] A TR-FRET competition 
binding assay shows that binding of 10 nM of red-CCK(26-33) is 
completely reversed in a dose dependent way by adding saturating 
amounts of the antagonist PD135158. The inhibition constant (Ki) is 
calculated to be 6 nM, in accordance with literature values. [21] 
 
 
 
 
 
 
Figure 2.  a) Cartoon showing a TR-FRET ligand binding assay on HEK293 
cells expressing SNAP-CCK2 (adapted from ref 3). b,c,d) Saturation curves for 
labeling HEK293 expressing SNAP-CCK2 and non-transfected cells at the cell 
surface using TR-detection (620 ± 5 nm, 60-460 s with [Eu.L
5
], [Eu.L
6
] and 
Eu.L
7
 respectively. e) Binding of red-CCK(26-33) to HEK293 cells expressing 
SNAP-CCK2 labeled with 200 nM of [Eu.L
7
] monitored by following the 665/620 
x10000 ratio. Non specific signal is measured by adding 10 M of unlabeled 
CCK(26-33)  f) TR-FRET competition binding assay, monitoring the dose-
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response curve for the displacement of red-CCK(26-33) by CCK2 antagonist 
PD135158.  
Since the non-specific labeling was suppressed we could also 
monitor the labeling of SNAP-CCK2 with Eu.L7 using time resolved 
microscopy. HEK293 cells (50k) were plated on a lab-tek slide, 
transfected with SNAP-CCK2 plasmid and incubated for 2 days 
after which they were labeled with 200 nM of Eu.L7 during 1h. 
Using a delay of 100 s and a gate-time of 2 ms, a typical TR-image 
recorded with a filter of 615±10 nm is shown in Figure 3a. Labeling 
clearly occurs at the cell surface and not within the cell.  
Only recently has lanthanide based time resolved FRET microscopy 
[3, 9, 22, 23] been reported, mainly using a Tb-complex. [3, 24, 25]] To 
pursue the venture with these complexes, we tested whether this 
technology can also be applied with these europium complexes to 
monitor ligand-receptor interactions on GPCR. Since a band-pass 
filter at 615 nm was used to detect the TR signal, we could also use 
the same set-up to monitor the time-resolved FRET signal at 670 nm. 
Similar to the plate-based assay (Figure 2e), the red fluorescent 
agonist of CCK2 was added to the cells labeled with Eu.L7. The TR-
FRET image, recorded at 670±20 nm suggests the formation of 
vesicles, indicating that many of the receptors previously expressed 
at the cell surface are now internalized together with the red-
fluorescent agonist through a ligand induced internalization process. 
The image data for both the europium and the TR-FRET channel for 
the conditions with or without CCK(26-33)-red (see Figure 3) 
reveals that the TR-FRET signal under the same imaging conditions 
is well above the intensity due to donor bleed-through in the TR-
FRET channel. Similarly the Eu-channel intensity is decreased due 
to the FRET process. 
 
 
Figure 3. a) Time resolved luminescence microscopy imaging of SNAP-CCK2 
transfected HEK-293 cells labeled with 200 nM [Eu.L
7
] monitored at 615 ± 10 
nm (ex=337 nm, 30 Hz, delay 100 s, gate= 2000 s.The scale bar in all images 
is 20 m  b) Bleed through signal of the labeled cells in the TR-FRET 670 ± 20 
nm channel. c) Eu channel image  after adding red-CCK(26-33) to cells 
prepared and monitored as in a), incubating 20 minutes and washing three 
times with Tag-lite buffer.  d)   as c) but imaging the TR-FRET channel. 
 
In conclusion, we have developed bright, kinetically stable, highly 
water soluble Eu3+ complexes whose emissive properties are 
unchanged following bio-conjugation. The C-substitution of the 
TACN ring with an aminoalkyl group (derived from S-lysine), 
creates a useful synthon that is easily functionalized with different 
antennae ligands[26] for use in  a range of different applications. By 
introducing sulphonate or carboxylate groups onto the aryl-alkynyl 
antennae, non-specific labeling of living HEK cells is suppressed, 
permitting the detection of the GPCR CCK2 using derivative Eu.L7. 
Using time-resolved detection, the TR-FRET ligand binding assays 
both on a plate reader and with TR-FRET microscopy are possible. 
The low non-specific interactions of these complexes with cells will 
be a great advantage for the development of novel HTRF assays 
where specific biological interactions are studied. 
Furthermore, by introducing different electron donating moieties on 
the aryl-ring, we are developing bioconjugates whose electronic 
absorption bands are bathochromically shifted,[9, 27] thereby 
improving their brightness for use in time-resolved confocal or two-
photon microscopy. 
Experimental Section 
MATERIAL AND METHODS 
 
Reagents 
The Tag-lite labeling medium (ref. LABMED), the SNAP-CCK2 plasmid for 
transient transfection of CCK2 receptors (ref. PSNAPCCK2) and (CCK(26-33)-
red) (ref. L0013RED) were obtained from Cisbio Bioassays. The CCK2 receptor 
antagonist PD135158 was purchased from Tocris. CKK(26-33) was obtained 
from Almac (Craigavon, UK) The 96-well plates were purchased from Greiner 
Bio-One (ref. 655086, Monroe, NC). 
 
Cell culture 
HEK293 wild-type cells  were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) glutaMAX (1966-021 ; Invitrogen, Carlsbad, CA) supplemented with 
10 % fetal bovine serum, 1% nonessential amino acids, 1% penicillin 
/streptomycin, 2mM HEPES. 
 
Transfection procedure 
Transient transfection was performed in 96-well plates using 100,000 cells per 
well according to a previously described protocol.
[21]  
Prior to cell seeding, wells 
of the plates were precoated with 50 µL of poly-L-ornithine for 30 min at 37 °C. 
The transfection mixture (per one well) was prepared by adding 100 ng of the 
SNAP-tag-CCK2 plasmid to 49 µL optiMEM medium and 0.8 µL of 
Lipofectamine 2000 (Invitrogen) and incubated for 20 min at room temperature 
prior addition in plates. Subsequently, 100 µL of HEK 293 cells at a density of 
10
6
 cell/ mL was distributed in each well of the plates. Plates were incubated 
overnight at 37 °C under 5 % CO2. 
 
Receptor labeling 
For the labeling of SNAP-CCK2 expressed HEK293 cells with Eu.L
5-7
 a 
previously described protocole
[21]
 was used. A concentration series ranging from 
0-500 nM was prepared in Tag-lite labeling medium. After incubation the 
transfection  mixture was removed from 96-well plates, and cells were treated 
with 50 µL of the prepared solutions and incubated for 1h at 37 °C under 5% 
CO2.  The unreacted  compounds were removed by washing each well 4 times 
with 100 µL of Tag-lite labeling medium. 
 
Fluorescent ligand binding assay 
Affinity of red-CCK(26-33) for the CCK2 receptors was determined by 
incubating labeled cells with increasing concentrations of the fluorescent ligand. 
The non-specific signal for each ligand concentration was determined by adding 
an excess of the corresponding unlabeled compound (10 µM CCK-26-33). In 
plates containing labeled cells with 100 µL of Tag-lite labeling medium 20 µL of 
unlabeled compound (CCK-26-33) was added followed by addition of 20 µL of 
fluorescent ligand red(CCK(26-33)). Plates were incubated at room temperature 
for 2 hours before the signal detection. 
 
Competition binding assay 
In competitive binding experiments a fixed concentration of fluorescent ligand 
(10 nM red-CCK(26-33) was used in presence of increasing concentrations of  
antagonist PD135158. In plates containing labeled cells with 100 µL of Tag-lite 
labeling medium was added 20µL of PD135158 followed by the addition of 10 
  
4 
µL of fluorescent ligand (red-CCK(26-33). Plates were incubated at room 
temperature for 4 hours before the signal detection. 
 
Signal detection and data analysis 
Signal detection was performed on PHERAstar FS plate reader (BMG 
LABTECH, Champigny-sur-Marne, France) at 620 nm and 665 nm (in TR 
mode : delay, 60 µs ; time gate, 400 µs) upon 337 nm laser excitation. 
Recorded data were analyzed using GraphPad Prism (GraphPad Software, Inc., 
San Diego, CA). Specific binding was determined by substracting nonspecific 
signal from the total signal. Kd values of the fluorescent ligand were obtained 
from the saturation curve of the specific binding. Ki values were calculated  from 
competition assay experiments according to the Cheng and Prusoff equation.
[28]
  
 
TR-FRET Microscopy 
Lab-Tek 8 chamber slide system was precoated with 200 µL poly-L-ornithine 
and incubated for 30 min at 37 °C. The slide was washed with 200 µL PBS, 
HEK 293 cells were plated at a density of 5 x 10
4
 c/w and incubated overnight 
at 37 °C under 5% CO2. The following day transfection was performed with 100 
µl optiMEM medium, 0.8 µL of Lipofectamine 2000 and 1.2 µg SNAP-CCK2 
plasmid (per well). The Lab-Tek slide was further incubated for 2 days at 37 °C 
under 5% CO2. After removal of the medium SNAP-CCK2 receptors were 
labeled with 200 nM of [Eu.L
7
] for 1h at 37 °C and washed 2 times with tag-lite 
medium. For the FRET signal detection 10 nM of red-CCK(26-33) was added. 
2µg/mL of Hoechst 33342 (per well) was added and after 20 min incubation at 
room temperature and washing twice with Tag-lite medium the Lab-Tek slide 
was observed with a Zeiss oil immersion objective (40x, 1.3 F-Fluar) on the 
Zeiss Axiovert 200M TR-FRET inverted microscope equipped with a pulsed 
nitrogen laser (337 nm, 30 Hz) and a cooled intensified CCD camera PI Max 
1024X1024 GenIII. For the luminescence imaging of   [Eu.L
7
] 615 ± 10 nm 
band-pass filter was used with a delay of 100 µs a gate of 2000 µs and at 60 
gates per exposure. TR-FRET images were collected with a 670 ± 20 nm band-
pass filter using the same set up as written above. The recorded data were 
analyzed using ImageJ software. 
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Schulmeister, A. C. Pfeifer, J. Bachmann, U. Klingmüller, V. Sourjik, 
D.-P. Herten, Anal. Chem. 2010, 82, 8186. 
[16] S. J. Butler, M. Delbianco, N. H. Evans, A. T. Frawley, R. Pal, D. 
Parker, R. S. Puckrin, D. S. Yufit, Dalton Trans. 2014, 43, 5721. 
[17] A. Keppler, H. Pick, C. Arrivoli, H. Vogel, K. Johnsson, Proc. Natl. 
Acad. Sci. USA 2004, 101, 9955. 
[18] G. Lukinavičius, K. Umezawa, N. Olivier, A. Honigmann, G. Yang, T. 
Plass, V. Mueller, L. Reymond, I. R. Corrêa Jr, Z.-G. Luo, C. Schultz, 
E. A. Lemke, P. Heppenstall, C. Eggeling, S. Manley, K. Johnsson, 
Nat Chem 2013, 5, 132. 
[19] D. Maurel, L. Comps-Agrar, C. Brock, M.-L. Rives, E. Bourrier, M. A. 
Ayoub, H. Bazin, N. Tinel, T. Durroux, L. Prézeau, E. Trinquet, J.-P. 
Pin, Nat Methods 2008, 5, 561. 
[20] L. Albizu, M. Cottet, M. Kralikova, S. Stoev, R. Seyer, I. Brabet, T. 
Roux, H. Bazin, E. Bourrier, L. Lamarque, C. Breton, M.-L. Rives, A. 
Newman, J. Javitch, E. Trinquet, M. Manning, J.-P. Pin, B. Mouillac, 
T. Durroux, Nat. Chem. Biol. 2010, 6, 587. 
[21] J. M. Zwier, T. Roux, M. Cottet, T. Durroux, S. Douzon, S. Bdioui, N. 
Gregor, E. Bourrier, N. Oueslati, L. Nicolas, N. Tinel, C. Boisseau, P. 
Yverneau, F. Charrier-Savournin, M. Fink, E. Trinquet, J. Biomol. 
Screening 2010 15 1248. 
[22] H. E. Rajapakse, N. Gahlaut, S. Mohandessi, D. Yu, J. R. Turner, L. 
W. Miller, Proc Natl Acad Sci USA 2010, 107, 13582. 
[23] M. Rajendran, E. Yapici, L. W. Miller, Inorg. Chem. 2014, 53, 1839. 
[24] D. Geißler, L. J. Charbonnière, R. Ziessel, N. G. Butlin, H.-G. 
Löhmannsröben, N. Hildebrandt, Angew. Chem. Int. Ed. 2010, 49, 
1396. 
[25] J. Xu, T. M. Corneillie, E. G. Moore, G.-L. Law, N. G. Butlin, K. N. 
Raymond, J. Am. Chem. Soc. 2011, 133, 19900. 
[26] M. Starck, P. Kadjane, E. Bois, B. Darbouret, A. Incamps, R. Ziessel, 
L. J. Charbonnière, Chem.-Eur. J. 2011, 17, 9164. 
[27] M. Soulié, F. Latzko, E. Bourrier, V. Placide, S. J. Butler, R. Pal, J. W. 
Walton, P. L. Baldeck, B. Le Guennic, C. Andraud, J. M. Zwier, L. 
Lamarque, D. Parker, O. Maury, Chem. -Eur. J. 2014, 20, in press 
DOI: 10.1002/chem.201402415. 
[28] Y. C. Cheng, W. H. Prusoff, Biochem. Pharmacol. 1973, 22, 3099. 
 
 
 
 
 
 
 
 
 
 
  
5 
Entry for the Table of Contents (Please choose one layout) 
 
 
Layout 1: 
Catch Phrase 
N N
N
N
N
P
P
O
O
O
O
Me
Me
Eu
N
P
O
O
Me
O
O
O
HN
O
O
N
H
O
HN
O
NH
SO3
-
HN
O
-O3S
NH
O
SO3
-
 
 
 
 
Bright and selective:  hydrophilic 
Eu(III) complexes have been created 
that suppress non-specific binding and 
permit their use in bio-conjugates using 
time-resolved assays exemplified for G-
protein coupled receptor antagonists. 
 
Martina Delbianco, Victoria 
Sadovnikova
+
, Emmanuel Bourrier, 
Gérard Mathis, Laurent Lamarque, 
Jurriaan M. Zwier* and David Parker*  
xxx – xxxy 
Bright, highly water soluble 
triazacyclononane europium 
complexes to detect ligand binding 
with time resolved-FRET microscopy  
 
 
 
 
 
 
